Analyst Reco. Imunon, Inc.

Equities

Delayed Nasdaq Other stock markets 04:00:00 2025-01-17 pm EST			5-day change	1st Jan Change
0.9131 ^USD	+1.68%		+1.47%	-3.88%

Dec. 19	IMUNON, Inc. Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer	CI
Dec. 10	Imunon Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 Ovation 2 Study of Imnn-001	CI

HC Wainwright Adjust Price Target on Imunon to $13 From $12, Keeps Buy Rating	24-04-01	MT
Alliance Global Starts Imunon at Buy with $15 Price Target	22-10-13	MT
HC Wainwright Starts Celsion at Buy With $16 Price Target	22-04-13	MT

No results for this search